Investing

Variances in regional health care spending are not limited to either private or public payers

Move puts Amazon squarely in the primary care space with locations in 16 major metro areas with more on the way

Report shows positive changes, but plenty of room for improvement to reduce the number of denials

Study outlines trends in recruiting incentives, market conditions.

Fewer deals, but big money dominates

No matter what your age or risk tolerance, investing is a lot easier and likely more successful if your perspective is informed by market history.

Consumer Price Index up 9.1% in June

Many investors are chagrined to learn that bonds, once a paragon of stability, are no longer an automatic solution for wealth preservation.

Proposed 2023 Medicare Physician Fee Schedule rule cuts conversion factor by 4.42%, meaning lower pay for treating Medicare patients

Survey from MGMA shows majority of doctors saw an increase since 2020

Many investors are looking for assets that don’t move with stocks and are inflation-proof. Are REITs the answer?

Revenue and volumes rise, but hospitals still performing below pre-pandemic levels

Physician practices remain a top target for investors

Former Treasury Secretary Larry Summers said the U.S. needs a significant rise in unemployment to stave off more inflation

Some patients report not paying because they either think their insurance will pay it or they think the bill is inaccurate

$500 million in expiring funding puts Medicare in jeopardy

Central bank attempting to slow inflation that is threatening the entire economy

The stock market has been volatile lately. Should this change your investment strategy?

Many investors are looking for assets that don’t move with stocks are inflation proof. Are REITs the answer?

The economics of direct care are straightforward. Here are the three variables to track.

Fear that a market-punishing recession is right around the corner seems ubiquitous.

American Hospital Association requesting a task force from the justice department to investigate commercial health insurance companies in the Medicare Advantage program

What can be done about it?

Eli Lilly and Company’s Mounjaro received FDA approval for its type 2 diabetes drug